Detalles de la búsqueda
1.
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
Ophthalmology;
2024 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280653
2.
Displacement of submacular hemorrhage using subretinal cocktail injection versus pneumatic displacement: a real-world comparative study.
Ophthalmologica;
2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38408445
3.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Lancet;
399(10326): 729-740, 2022 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085502
4.
Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials.
Graefes Arch Clin Exp Ophthalmol;
261(11): 3125-3137, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294433
5.
Myopic macular diseases: A review.
Clin Exp Ophthalmol;
51(3): 229-242, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594934
6.
PREDICTORS AND IMPORTANCE OF COMPLETE POLYPOIDAL LESION REGRESSION IN THE EVEREST II STUDY: Predictors of Polyp Regression in Polypoidal Choroidal Vasculopathy.
Retina;
42(11): 2091-2098, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963005
7.
Visualising the choriocapillaris: Histology, imaging modalities and clinical research - A review.
Clin Exp Ophthalmol;
50(1): 91-103, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387023
8.
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.
Ophthalmology;
128(3): 443-452, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32795496
9.
Pachychoroid: current concepts on clinical features and pathogenesis.
Graefes Arch Clin Exp Ophthalmol;
259(6): 1385-1400, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33057904
10.
RANIBIZUMAB WITH OR WITHOUT VERTEPORFIN PHOTODYNAMIC THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY: Predictors of Visual and Anatomical Response in the EVEREST II Study.
Retina;
41(2): 387-392, 2021 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33475271
11.
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review.
Retina;
41(1): 1-19, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33136975
12.
REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS Study.
Retina;
40(8): 1529-1539, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385918
13.
Identification and characterization of a novel promoter variant in placental growth factor for neovascular age-related macular degeneration.
Exp Eye Res;
187: 107748, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31377148
14.
EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials.
Retina;
39(3): 537-547, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29280937
15.
RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION: BRILLIANCE, a 12-Month, Randomized, Double-Masked Study.
Retina;
39(10): 1985-1994, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30204730
16.
Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUS.
Ophthalmology;
125(6): 850-862, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29371007
17.
Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
Ophthalmology;
125(5): 708-724, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331556
18.
An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study.
Graefes Arch Clin Exp Ophthalmol;
256(5): 963-973, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29502232
19.
EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study.
Retina;
38(8): 1464-1477, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28704254
20.
Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management.
Ophthalmology;
124(11): 1690-1711, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28655539